Aurinia Pharmaceuticals
AUPH
#4785
Rank
HK$15.51 B
Marketcap
HK$115.82
Share price
-0.77%
Change (1 day)
-2.14%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2026 (TTM): HK$18.64

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$18.74. In 2025 the company made an earnings per share (EPS) of HK$17.01 an increase over its 2024 EPS that were of HK$0.39.

EPS history for Aurinia Pharmaceuticals from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$18.649.6%
2025HK$17.014240%
2024HK$0.39
2022-HK$5.96-46.1%
2021-HK$11.0563.95%
2020-HK$6.74-33.85%
2019-HK$10.1973.33%
2018-HK$5.88-34.78%
2017-HK$9.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
HK$368.28 1,865.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-HK$137.97-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.06-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA